• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
[Characteristics of intestinal microbiota in the acute phase of Kawasaki disease in infants and children].[婴幼儿川崎病急性期肠道微生物群的特征]
Zhongguo Dang Dai Er Ke Za Zhi. 2024 Oct 15;26(10):1101-1107. doi: 10.7499/j.issn.1008-8830.2405111.
2
Altered gut microbiota correlated with systemic inflammation in children with Kawasaki disease.川崎病患儿肠道菌群改变与全身炎症相关。
Sci Rep. 2020 Sep 3;10(1):14525. doi: 10.1038/s41598-020-71371-6.
3
Alteration of the oral and gut microbiota in patients with Kawasaki disease.川崎病患者口腔和肠道微生物群的改变。
PeerJ. 2023 Jul 10;11:e15662. doi: 10.7717/peerj.15662. eCollection 2023.
4
Gut Microbiota Alterations in Patients With Kawasaki Disease.川崎病患者的肠道微生物群改变
Arterioscler Thromb Vasc Biol. 2025 Mar;45(3):345-358. doi: 10.1161/ATVBAHA.124.321201. Epub 2025 Jan 23.
5
Interplay of gut microbiota in Kawasaki disease: role of gut microbiota and potential treatment strategies.肠道微生物群在川崎病中的相互作用:肠道微生物群的作用及潜在治疗策略
Future Microbiol. 2025 Mar;20(4):357-369. doi: 10.1080/17460913.2025.2469432. Epub 2025 Feb 27.
6
Dysbiosis of the gut microbiota as a susceptibility factor for Kawasaki disease.肠道微生物失调作为川崎病易感性因素。
Front Immunol. 2023 Oct 31;14:1268453. doi: 10.3389/fimmu.2023.1268453. eCollection 2023.
7
Characteristic profile of intestinal microflora in Kawasaki disease.川崎病肠道微生物群的特征图谱。
Acta Paediatr. 2002;91(7):783-8. doi: 10.1080/08035250213221.
8
Metagenomic analysis demonstrates distinct changes in the gut microbiome of Kawasaki diseases children.宏基因组分析表明川崎病患儿肠道微生物组有明显变化。
Front Immunol. 2024 Jul 22;15:1416185. doi: 10.3389/fimmu.2024.1416185. eCollection 2024.
9
Correlation of gut microbial compositions to the development of Kawasaki disease vasculitis in children.肠道微生物组成与儿童川崎病血管炎发展的相关性。
Future Microbiol. 2020 May;15:591-600. doi: 10.2217/fmb-2019-0301. Epub 2020 Jun 3.
10
Effects of changes on gut microbiota in children with acute Kawasaki disease.急性川崎病患儿肠道微生物群变化的影响
PeerJ. 2020 Aug 6;8:e9698. doi: 10.7717/peerj.9698. eCollection 2020.

本文引用的文献

1
Kawasaki Disease-Associated Cytokine Storm Syndrome.川崎病相关细胞因子风暴综合征。
Adv Exp Med Biol. 2024;1448:365-383. doi: 10.1007/978-3-031-59815-9_25.
2
The rapidly progressing and fatal outcome of rhombencephalitis by listeriosis in a 61-year-old male.一名61岁男性因李斯特菌病导致的菱形脑炎进展迅速并最终死亡。
Ann Agric Environ Med. 2024 Jun 27;31(2):311-314. doi: 10.26444/aaem/178178. Epub 2024 Mar 4.
3
The chaperone PrsA2 regulates the secretion, stability, and folding of listeriolysin O during infection.伴侣蛋白PrsA2在感染过程中调节溶血素O的分泌、稳定性和折叠。
mBio. 2024 Jul 17;15(7):e0074324. doi: 10.1128/mbio.00743-24. Epub 2024 May 29.
4
Dysbiosis of the gut microbiota as a susceptibility factor for Kawasaki disease.肠道微生物失调作为川崎病易感性因素。
Front Immunol. 2023 Oct 31;14:1268453. doi: 10.3389/fimmu.2023.1268453. eCollection 2023.
5
Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.解析微生物组在神经源性高血压中的作用的机制见解:全面综述。
Pathol Res Pract. 2023 Sep;249:154740. doi: 10.1016/j.prp.2023.154740. Epub 2023 Aug 6.
6
Alteration of the oral and gut microbiota in patients with Kawasaki disease.川崎病患者口腔和肠道微生物群的改变。
PeerJ. 2023 Jul 10;11:e15662. doi: 10.7717/peerj.15662. eCollection 2023.
7
Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials.儿童川崎病的药物干预:56项随机对照试验的网状Meta分析
EBioMedicine. 2022 Apr;78:103946. doi: 10.1016/j.ebiom.2022.103946. Epub 2022 Mar 17.
8
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease.2021年美国风湿病学会/血管炎基金会川崎病管理指南
Arthritis Care Res (Hoboken). 2022 Apr;74(4):538-548. doi: 10.1002/acr.24838. Epub 2022 Mar 7.
9
Enhances Early-Stage Infection by Inhibiting the Inflammatory Response.增强早期感染,抑制炎症反应。
Front Cell Infect Microbiol. 2022 Feb 10;11:748461. doi: 10.3389/fcimb.2021.748461. eCollection 2021.
10
Development of the gut microbiome in early life.生命早期肠道微生物组的发育。
Exp Physiol. 2022 May;107(5):415-421. doi: 10.1113/EP089919. Epub 2022 Jan 30.

[婴幼儿川崎病急性期肠道微生物群的特征]

[Characteristics of intestinal microbiota in the acute phase of Kawasaki disease in infants and children].

作者信息

Wang Hong-Mao, Zhang Ming-Ming, Lin Yao, Liu Yang, Xue Guan-Hua, Shi Lin, Yuan Jing, Li Xiao-Hui

机构信息

Department of Cardiovascular Disease, Children's Hospital Affiliated to Capital Institute of Pediatrics, Beijing 100020, China.

出版信息

Zhongguo Dang Dai Er Ke Za Zhi. 2024 Oct 15;26(10):1101-1107. doi: 10.7499/j.issn.1008-8830.2405111.

DOI:10.7499/j.issn.1008-8830.2405111
PMID:39467681
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11527410/
Abstract

OBJECTIVES

To study the composition, abundance, and functional profiles of the intestinal microbiota in infants and young children with Kawasaki disease (KD) during the acute phase, and to explore the potential role of intestinal microbiota in the pathogenesis of KD.

METHODS

Six children aged 0-3 years with acute KD admitted to the Department of Cardiology, Children's Hospital Affiliated to Capital Institute of Pediatrics from July to October 2021 were prospectively included as the KD group. Six age- and sex-matched healthy children who underwent physical examinations at the hospital during the same period were selected as the healthy control group. Metagenomics sequencing was used to detect and compare the differences in the microflora structure and functional profiles of fecal samples between the two groups.

RESULTS

There were significant differences in the structural composition and diversity of intestinal microbiota between the two groups (<0.05). Compared with the healthy control group, the abundance of _ (family and genus ), _, _, and _ was significantly higher in the intestinal microbiota in the KD group (LDA>2.0, <0.05). The steroid degradation and apoptosis pathways were significantly upregulated in the KD group compared with the healthy control group, while the Bacterial_secretion_system, Sulfur_metabolism, Butanoate_metabolism, Benzoate_degradation, β-alanine metabolism, and α-linolenic acid pathways were significantly downregulated (|LDA|>2, <0.05).

CONCLUSIONS

There are significant differences in the structure and diversity of intestinal microbiota between children aged 0-3 years with acute KD and healthy children, suggesting that disturbances in intestinal microbiota occur during the acute phase of KD. In particular, _, _, and _ may be involved in the pathogenesis of KD through steroid degradation and apoptosis pathways.

摘要

目的

研究川崎病(KD)婴幼儿急性期肠道微生物群的组成、丰度和功能概况,探讨肠道微生物群在KD发病机制中的潜在作用。

方法

前瞻性纳入2021年7月至10月首都儿科研究所附属儿童医院心内科收治的6例0 - 3岁急性KD患儿作为KD组。选取同期在该院进行体检的6例年龄和性别匹配的健康儿童作为健康对照组。采用宏基因组测序检测并比较两组粪便样本中微生物群落结构和功能概况的差异。

结果

两组肠道微生物群的结构组成和多样性存在显著差异(<0.05)。与健康对照组相比,KD组肠道微生物群中_(科和属)、_、_和_的丰度显著更高(LDA>2.0,<0.05)。与健康对照组相比,KD组类固醇降解和凋亡途径显著上调,而细菌分泌系统、硫代谢、丁酸代谢、苯甲酸降解、β-丙氨酸代谢和α-亚麻酸途径显著下调(|LDA|>2,<0.05)。

结论

0 - 3岁急性KD患儿与健康儿童的肠道微生物群结构和多样性存在显著差异,提示KD急性期存在肠道微生物群紊乱。特别是,_、_和_可能通过类固醇降解和凋亡途径参与KD的发病机制。